0001225208-16-031947.txt : 20160428 0001225208-16-031947.hdr.sgml : 20160428 20160428162244 ACCESSION NUMBER: 0001225208-16-031947 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160427 FILED AS OF DATE: 20160428 DATE AS OF CHANGE: 20160428 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP CENTRAL INDEX KEY: 0000885725 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042695240 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 BUSINESS PHONE: 508-683-4000 MAIL ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ballinger Kevin J. CENTRAL INDEX KEY: 0001566080 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11083 FILM NUMBER: 161600412 MAIL ADDRESS: STREET 1: C/O BOSTON SCIENTIFIC CORPORATION STREET 2: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 4 1 doc4.xml X0306 4 2016-04-27 0000885725 BOSTON SCIENTIFIC CORP BSX 0001566080 Ballinger Kevin J. 300 BOSTON SCIENTIFIC WAY MARLBOROUGH MA 01752-1234 1 SVP & Pres, Interven Cardio Common Stock 2016-04-27 4 M 0 36630.0000 7.7100 A 83600.0000 D Common Stock 2016-04-27 4 M 0 35000.0000 8.3000 A 118600.0000 D Common Stock 2016-04-27 4 M 0 23077.0000 7.4100 A 141677.0000 D Common Stock 2016-04-27 4 M 0 17100.0000 15.9100 A 158777.0000 D Common Stock 2016-04-27 4 S 0 111807.0000 21.6156 D 46970.0000 D Stock Option (Right to Buy) 7.4100 2016-04-27 4 M 0 23077.0000 0.0000 D 2020-02-16 Common Stock 23077.0000 0.0000 D Stock Option (Right to Buy) 8.3000 2016-04-27 4 M 0 35000.0000 0.0000 D 2019-02-24 Common Stock 35000.0000 0.0000 D Stock Option (Right to Buy) 7.7100 2016-04-27 4 M 0 36630.0000 0.0000 D 2018-10-28 Common Stock 36630.0000 0.0000 D Stock Option (Right to Buy) 15.9100 2016-04-27 4 M 0 17100.0000 0.0000 D 2016-10-31 Common Stock 17100.0000 0.0000 D The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan. Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available. Represents the weighted average sale price. These shares were sold in multiple transactions at $21.40 and $22.00. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Grant to the reporting person of an option to purchase a specified number of shares of common stock on February 16, 2010. This option is fully vested. Grant to the reporting person of an option to purchase a specified number of shares of common stock on February 24, 2009. This option is fully vested. Grant to the reporting person of an option to purchase a specified number of shares of common stock on October 28, 2008. This option is fully vested. Grant to the reporting person of an option to purchase a specified number of shares of common stock on October 31, 2006. This option is fully vested /s/ Lee G. Giguere, Attorney-in-Fact 2016-04-28